AMMAN—A U.S. decision on Pfizer (PFE.N) and BioNTech's COVID-19
vaccine for children 6 months through 4 years of age has been postponed for at
least two months after the Food and Drug Administration said it needed more
data, according to the Jordan News Agency, Petra.
اضافة اعلان
The FDA had planned to make a decision on the vaccine based
on early trial data because of what it had called a great public health need
due to the surge in infections caused by the Omicron variant of the
coronavirus. The decision was slated for next week with a rollout starting as
soon as Feb. 21.
On Friday, the agency said it had reviewed new trial
information that had come in since Pfizer and BioNTech's request for emergency
authorization and decided it needed more data before moving forward.
The FDA said parents anxiously awaiting the vaccine for
their younger kids should be reassured that the agency is taking the time to
make sure it meets the standard it has set for authorization.
Read more
Region and World news.
.jpg)
.jpg)
